+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lurasidone"

LATUDA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LATUDA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
Bipolar Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Bipolar Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States and Japan LATUDA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Japan, United States Japan, United States
From
From
From
Schizophrenia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Schizophrenia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Lurasidone is a medication used to treat mental disorders such as schizophrenia and bipolar disorder. It is an atypical antipsychotic drug that works by blocking certain receptors in the brain, which helps to reduce symptoms such as hallucinations, delusions, and disorganized thinking. It is also used to treat depression and anxiety. Lurasidone is generally well-tolerated and has fewer side effects than other antipsychotic medications. The lurasidone market is a growing segment of the mental disorders drugs market. It is a relatively new drug, having been approved by the FDA in 2009, and is gaining popularity due to its effectiveness and low side effects. It is used in both the short-term and long-term treatment of mental disorders. Some companies in the lurasidone market include Sunovion Pharmaceuticals, Intas Pharmaceuticals, and Dr. Reddy's Laboratories. Show Less Read more